PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.87M | 10.44M | 9.97M | 8.69M | 8.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.87M | 10.44M | 9.97M | 8.69M | 8.62M |
| Cost of Revenue | 13.89M | 7.69M | 7.55M | 6.70M | 6.46M |
| Gross Profit | 3.98M | 2.74M | 2.42M | 1.99M | 2.16M |
| SG&A Expenses | 2.75M | 2.84M | 1.80M | 1.49M | 1.53M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.94M | 10.79M | 9.55M | 8.35M | 8.14M |
| Operating Income | 931.40K | -353.40K | 420.20K | 340.90K | 478.30K |
| Income Before Tax | 1.03M | -466.60K | 420.40K | 329.10K | 509.10K |
| Income Tax Expenses | 241.20K | -280.20K | 115.90K | 73.70K | 196.60K |
| Earnings from Continuing Operations | 789.10K | -186.40K | 304.50K | 255.40K | 312.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 789.10K | -186.40K | 304.50K | 255.40K | 312.50K |
| EBIT | 931.40K | -353.40K | 420.20K | 340.90K | 478.30K |
| EBITDA | 1.13M | 4.00K | 471.40K | 384.00K | 554.20K |
| EPS Basic | 0.04 | -0.01 | 0.02 | 0.01 | 0.02 |
| Normalized Basic EPS | 0.03 | -0.01 | 0.01 | 0.01 | 0.02 |
| EPS Diluted | 0.04 | -0.01 | 0.02 | 0.01 | 0.02 |
| Normalized Diluted EPS | 0.03 | -0.01 | 0.01 | 0.01 | 0.02 |
| Average Basic Shares Outstanding | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M |
| Average Diluted Shares Outstanding | 20.00M | 20.00M | 20.00M | 20.00M | 20.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |